AS&E v. Viken Detection: X-ray Scanning Patent Dispute Settles After 1,444 Days
American Science and Engineering, Inc. filed suit against Viken Detection Corp. in Massachusetts federal court, asserting three X-ray scanning patents against Viken’s Osprey-EVX and Osprey-UVX products. The case closed after nearly four years under a confidential settlement, with both parties bearing their own costs.
Four-Year X-ray Patent Battle Ends in Confidential Settlement
American Science and Engineering, Inc. (AS&E), a long-established developer of X-ray security screening technology, filed this infringement action against Viken Detection Corp. on October 19, 2020 in the District of Massachusetts before Judge Leo T. Sorokin. AS&E asserted three patents — US7505562B2, US8300763B2, and US11143783B2 — against Viken’s Osprey-EVX and Osprey-UVX portable X-ray scanning products, which compete directly in the security and threat-detection imaging market.
The case closed on October 2, 2024, via a stipulated dismissal with prejudice under Fed. R. Civ. P. 41(a)(1)(A)(ii), reflecting a confidential settlement reached between the parties. Dismissal with prejudice means neither party may re-litigate the same claims in federal court. The cost-sharing arrangement — each side bearing its own fees — suggests a negotiated resolution rather than a capitulation by either party, though the financial terms remain undisclosed.
The litigation ran 1,444 days, which is notably extended for a district-court patent matter and suggests substantive contested proceedings before settlement was reached. The involvement of three patents across different application numbers — spanning filings from 2007 through 2021 — indicates AS&E pursued a multi-generational IP strategy. The precise trigger for settlement and any licensing terms remain shielded by confidentiality, leaving the ultimate commercial outcome opaque from the public record.
Filing to Case Dismissed in 1444 days
Nearly 4 years — longer than the median patent case in D. Mass.
Dismissed with prejudice: what the confidential settlement means for both parties
Rule 41(a)(1)(A)(ii) dismissal with prejudice explained
A stipulated dismissal with prejudice under Fed. R. Civ. P. 41(a)(1)(A)(ii) requires agreement of all parties and operates as a final judgment on the merits. AS&E cannot re-assert the same patent claims against Viken for the same accused products in federal court. This is the standard vehicle for converting a settlement agreement into a binding court disposition without a trial.
No re-litigation possibleAS&E retains patents; settlement terms undisclosed
AS&E’s three X-ray scanning patents remain valid and in force — a settlement does not constitute an invalidity finding. The confidential settlement may include a license, royalty stream, or design-around commitment from Viken, but the public record is silent on these terms. AS&E retains the ability to assert the same patents against other parties in the security imaging market.
Patents survive; terms confidentialViken avoids infringement finding but faces ongoing patent risk
Viken secured dismissal without a court ruling on infringement or validity — potentially the best realistic outcome short of winning on the merits. However, the with-prejudice dismissal only bars AS&E from re-suing on the same claims for the same products. Viken’s future Osprey-series iterations or new product lines could face renewed scrutiny under the same patent family if not covered by any settlement license.
No merits ruling; forward risk remainsSettled disputes leave competitive landscape ambiguous
Confidential settlements in security imaging IP disputes typically signal that the asserted patents carried sufficient licensing leverage to motivate resolution. AS&E’s multi-generational patent portfolio — covering backscatter and scanning systems from 2007 through 2021 — represents ongoing risk for competitors in the portable X-ray segment. Other Osprey-class product developers should evaluate FTO exposure against the surviving AS&E patent family.
Portfolio risk for portable X-ray sectorFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | American Science and Engineering, Inc. | Company | X-ray security imaging company — holder of US7505562B2, US8300763B2, US11143783B2Search in Eureka ↗ |
| Defendant | Viken Detection, Corp. | Company | Viken Detection Corp. — developer of portable X-ray scanning systems including Osprey seriesSearch in Eureka ↗ |
| Plaintiff counsel | Aaron E. Hankel | Attorney | Counsel for American Science and Engineering, Inc.Search in Eureka ↗ |
| Plaintiff counsel | B. Trent Webb | Attorney | Counsel for American Science and Engineering, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Lauren E. Douville | Attorney | Counsel for American Science and Engineering, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Melissa Nott Davis | Attorney | Counsel for American Science and Engineering, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Samuel J. LaRoque | Attorney | Counsel for American Science and Engineering, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Shook Hardy Bacon LLP | Law Firm | Representing American Science and Engineering, Inc.Search in Eureka ↗ |
| Defendant counsel | Christopher K. Albert | Attorney | Counsel for Viken Detection, Corp.Search in Eureka ↗ |
| Defendant counsel | Christopher S. Schultz | Attorney | Counsel for Viken Detection, Corp.Search in Eureka ↗ |
| Defendant counsel | Jasjit S. Vidwan | Attorney | Counsel for Viken Detection, Corp.Search in Eureka ↗ |
| Defendant counsel | Keith J. Wood | Attorney | Counsel for Viken Detection, Corp.Search in Eureka ↗ |
| Defendant counsel | Laura L. Carroll | Attorney | Counsel for Viken Detection, Corp.Search in Eureka ↗ |
| Defendant counsel | Lawrence P. Cogswell, III | Attorney | Counsel for Viken Detection, Corp.Search in Eureka ↗ |
| Defendant counsel | Samuel J. Sussman | Attorney | Counsel for Viken Detection, Corp.Search in Eureka ↗ |
| Defendant law firm | ArentFox Schiff LLP | Law Firm | Representing Viken Detection, Corp.Search in Eureka ↗ |
| Defendant law firm | Hamilton, Brook, Smith & Reynolds PC | Law Firm | Representing Viken Detection, Corp.Search in Eureka ↗ |
| Presiding judge | Judge Leo T. Sorokin | Judge | Massachusetts District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulated dismissal cites Rule 41(a)(1)(A)(ii) and expressly references a confidential settlement agreement as its basis, indicating both parties negotiated terms before approaching the court. The with-prejudice designation forecloses any future federal action by AS&E on these specific claims against Viken’s current accused products. Crucially, the order contains no validity or infringement finding — meaning neither party secured a precedential ruling, and the patents remain fully enforceable against third parties.
US7505562B2, US8300763B2 & US11143783B2 — X-ray backscatter scanning systems
The three asserted patents — US7505562B2 (application filed 2007), US8300763B2 (application filed 2010), and US11143783B2 (application filed 2021) — collectively cover X-ray backscatter and transmission scanning technologies used in security inspection systems. AS&E has historically been a foundational developer of backscatter X-ray technology, and this multi-generational filing sequence suggests a deliberate strategy to maintain IP coverage as the underlying hardware and signal-processing architectures evolved over nearly fifteen years.
In the portable and vehicle-mounted X-ray scanning market — where Viken’s Osprey-EVX and Osprey-UVX products compete — AS&E’s patents represent a significant barrier to entry. The 2021 filing of US11143783B2 during active litigation is consistent with a continuation prosecution strategy intended to track Viken’s product design and maintain claim relevance. Other manufacturers of handheld or mobile X-ray security systems operating in customs, military, and law-enforcement channels should treat this portfolio as an active litigation risk.
Should your X-ray scanning product be cleared against AS&E’s portfolio?
Any company developing or commercialising portable X-ray backscatter or transmission scanning systems — particularly those aimed at security, customs, or military markets — should conduct FTO analysis against AS&E’s three asserted patents and their broader prosecution family. The Osprey product category is closely analogous to a range of competing handheld and vehicle-mounted X-ray systems. A settlement outcome leaves claim scope legally unresolved, making independent FTO analysis essential before product launch or market entry.
PatSnap Eureka’s FTO Search Agent can map your product’s technical features against the independent claims of US7505562B2, US8300763B2, and US11143783B2, identify continuation applications still in prosecution, and surface design-around pathways. Eureka’s prosecution history analysis tool also lets you trace how AS&E’s claim language has shifted across the three application generations — critical intelligence for any competitor assessing long-term freedom to operate in the X-ray security imaging space.
Run a freedom-to-operate analysis on US7505562B2 to assess your product’s exposure
Run FTO in Eureka →Similar X-ray security scanning patent cases in U.S. district courts
Cases involving X-ray backscatter and threat-detection imaging patents litigated in U.S. district courts, with comparable multi-patent enforcement and security-sector defendants.
What this case signals for the security imaging IP landscape
A confidential settlement after nearly four years suggests AS&E’s patent portfolio carries real commercial weight in the X-ray detection market.
Multi-patent assertions raise the cost of defense substantially
AS&E asserted three patents spanning filings from 2007 to 2021, consistent with a portfolio enforcement strategy designed to foreclose design-around options. Companies competing in portable X-ray scanning should audit exposure across all three patent families, not just the most recent grant.
Confidential settlements preserve enforcement optionality for patent holders
Because settlement terms are undisclosed, AS&E can enforce identical patents against other competitors without revealing what concessions, if any, it made to Viken. This asymmetric information advantage is a standard feature of confidential IP settlements and materially benefits the patent holder in future enforcement actions.
American v Viken — key questions answered
AS&E asserted three patents: US7505562B2, US8300763B2, and US11143783B2. These cover X-ray backscatter and transmission scanning technologies. The accused products were Viken’s Osprey-EVX and Osprey-UVX portable X-ray scanning systems.
The case was dismissed with prejudice on October 2, 2024, pursuant to a stipulated dismissal under Fed. R. Civ. P. 41(a)(1)(A)(ii) and a confidential settlement agreement. Each party bore its own costs, expenses, and attorney fees. No court ruling on infringement or validity was issued.
No. A dismissal with prejudice only bars AS&E from re-suing Viken on the same claims for the same accused products. The three asserted patents remain valid and enforceable against other third parties. Competitors in the portable X-ray security market retain independent FTO exposure under AS&E’s portfolio.
The 1,444-day duration — nearly four years — is consistent with a contested patent case proceeding through claim construction, fact discovery, and potentially expert proceedings or summary judgment before the parties reached settlement. The public record does not disclose the specific procedural milestones that preceded the settlement agreement.
US11143783B2 was filed in 2021, one year after the lawsuit commenced in 2020. This timing is consistent with a continuation prosecution strategy, where a patent holder files new claims to track or cover evolving accused product designs. It suggests AS&E was actively managing its prosecution portfolio during the litigation, which is a common tactic to maintain or broaden claim coverage relevant to the accused products.
PatSnap Eureka searches patents and litigation data to answer instantly.